87 citations
,
December 2020 in “Journal of Materials Chemistry B” This study found that a nanofiber wound dressing made of CQD/Si NP/SF significantly inhibits bacterial growth and accelerates skin wound healing and hair follicle regeneration in animal models.
62 citations
,
January 2013 in “Skin Pharmacology and Physiology” This study found that low serum ferritin and vitamin D2 levels are associated with hair loss in females with chronic telogen effluvium and female pattern hair loss, suggesting potential benefits of screening and supplementation.
12 citations
,
March 2016 in “BBA clinical” This study found that intracellular Toll-like receptors were significantly up-regulated in peripheral blood mononuclear cells of alopecia areata patients, suggesting a potential role in inflammatory signaling and pathogenesis.
10 citations
,
March 2014 in “Scandinavian journal of clinical and laboratory investigation” This study found that MDA-modified DNA may contribute to immune responses in alopecia areata patients by creating neo-epitopes, providing new insights into the condition's immunological mechanisms.
5 citations
,
October 2018 in “Journal of Cosmetic Dermatology” This study found that oral pulse steroids significantly reduced serum and tissue levels of TNF-α in patients with alopecia areata, correlating with clinical improvement.
3 citations
,
September 2017 in “Archives of dermatological research” Early diagnosis and tailored treatments are crucial for managing ichthyosis syndromes with hair abnormalities.
1 citations
,
October 2018 in “Sohag Medical Journal” This study found that pregnant women commonly experience physiological skin changes, such as pigmentary alterations, and are susceptible to various dermatological conditions, including scabies and pregnancy-specific dermatoses.
September 2025 in “The Professional Medical Journal” In this study, 5mg oral minoxidil given daily for 24 weeks significantly increased hair thickness and scalp appearance among 27 male patients with androgenetic alopecia, although some experienced side effects like hypertrichosis and mild headaches.
January 2025 in “Advancements in Life Sciences” This study found that both autogenic and allogenic PRP therapies significantly improved wound contraction and healing in rabbits by day 15 and achieved complete wound closure by day 21, outperforming control and heterogenic PRP treatments.
In this randomized controlled trial at Bolan Medical Complex Hospital, researchers observed that liquid nitrogen cryotherapy increased hair regrowth by 60% in alopecia areata patients, significantly outperforming alternative treatments, which achieved 40% regrowth.
April 2024 in “Research Square (Research Square)” This case report describes a 27-year-old male with autoimmune polyglandular syndrome type 1, characterized by symptoms including fever, dysarthria, dysphagia, oral candidiasis, nail dystrophy, alopecia, hypoparathyroidism, and dilated cardiomyopathy. The study highlights unique bilateral symmetrical brain calcifications and underscores the syndrome’s diverse manifestations.
June 2023 in “Biological & clinical sciences research journal” This randomized controlled trial found that methotrexate, particularly when combined with low-dose prednisone, was effective in promoting hair regrowth in patients with alopecia areata totalis, with the combination treatment showing higher efficacy and faster results.
October 2022 in “International Journal of Homoeopathic Sciences” This case report describes a 28-year-old male patient with alopecia areata who received Natrium Muriaticum as an individualized homeopathic treatment for hair loss in his beard area, but it provides no broader clinical findings.
April 2020 in “El-Minia Medical Bulletin” This study examined the correlation between vitamin D, its receptor, and chronic telogen effluvium in females, identifying possible links between these factors and increased hair shedding.
January 2022 in “The Egyptian Journal of Hospital Medicine” This study found that combining fractional CO2 laser with 5% minoxidil was more effective than using 5% minoxidil alone for treating male androgenetic alopecia, and no serious adverse effects were identified.
15 citations
,
May 2016 in “Archives of Dermatological Research” This study found significantly higher levels of the protein ULBP3 in patients with alopecia areata incognita compared to other hair loss conditions and healthy controls, suggesting ULBP3's potential as a diagnostic marker for AAI.
4 citations
,
January 2022 in “Australasian Journal of Dermatology” This study found that serum HDAC1 levels are significantly higher in patients with alopecia areata compared to those with acne vulgaris and healthy controls, suggesting potential therapeutic opportunities for HDAC inhibitors.
1 citations
,
October 2014 in “Skin Pharmacology and Physiology” This study found that osteopontin expression was significantly higher in alopecia areata lesions compared to healthy controls, suggesting it may play a role in the disease's pathogenesis.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study developed a new triamcinolone acetonide serum combined with a microneedling device, showing promise for treating alopecia areata by targeting hair follicles in a less invasive, patient-friendly way with confirmed drug solubility, compatibility, and safety.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study developed a low-viscosity triamcinolone acetonide serum, used with a derma stamp microneedling device, to improve targeted treatment of alopecia areata, reporting favorable drug solubility, spreadability, and permeation to hair follicles, while maintaining skin safety.
January 2026 in “Dermatologic Therapy” This study found that a shampoo containing 1% selenium sulfide and 1% salicylic acid significantly improved the clinical signs and symptoms of seborrheic dermatitis and dandruff over an 8-week period.
December 2025 in “Saudi Journal of Medicine and Public Health” This narrative review highlights the critical role of pharmacists in optimizing topical corticosteroid therapy through proper agent selection, dosing, and patient education to manage various steroid-responsive skin conditions effectively.
October 2025 in “SHILAP Revista de lepidopterología” In this study, researchers in Sulaimani Governorate, Iraq found that androgenetic alopecia in adults was more prevalent in females than males, with significant risk factors including family history, recent surgeries, and frequent use of hair styling tools.
July 2025 in “UCP Journal of Science & Technology” This research conducted in Narowal, Pakistan, found significant differences in hematological and renal function parameters between pregnant and non-pregnant women, suggesting that these tests could serve as biomarkers for pregnancy.
October 2024 in “University of Thi-Qar Journal of Medicine” This study found that PRP therapy, topical treatments, and pharmacological interventions were effective in reducing hair loss among adults in Sulaimani Province.
November 2023 in “Deleted Journal” In this study, multimedia education significantly improved the knowledge and practices of women with polycystic ovarian syndrome, particularly in managing symptoms like menstrual irregularity and oligomenorrhea, as observed in a sample from the Sohag University Hospital clinic in Egypt.
40 citations
,
March 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” This study visualized mitochondrial metabolism in cultured bovine hair follicles and plucked human hairs, finding that ROS and mitochondrial polarization correlate in specific hair follicle regions, particularly near keratin deposition sites.
April 2026 in “Global Journal of Health Science” This study observed that patients with hypothyroidism-associated hair loss commonly have deficiencies in several vitamins and minerals, suggesting that these deficiencies may be linked to their condition.
July 2025 in “Journal of Investigative Dermatology” IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.
May 2013 in “Journal of the Egyptian Women's Dermatologic Society (Print)” In this study, elevated serum levels of aldosterone and free testosterone, along with increased androgen and aldosterone receptor levels, were associated with early-onset androgenetic alopecia in female patients.